Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 1 of 25, showing 10 Applications out of 243 total, starting on record 1, ending on 10

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

1.

ECCT/26/06/03   C1091009 - Study Site 1254
    Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants   
Principal Investigator(s)
1. Fredrick Kipyego Sawe
Site(s) in Kenya
1. Kenya Medical Research Institute Walter Reed Project (Kericho county)
2. KEMRI Butere Clinical Research Centre (Kakamega county)
3. Kenya Medical Research Institute (KEMRI) - Centre for Global Health Research (Kisumu county)
4. Victoria Biomedical Research Institute Kisumu County Referral Hospital (Kisumu county)
 
08-11-2026 View

2.

ECCT/26/06/02   HibiscusJr
    A global phase 3 Randomised, Double-blind and Placebo-controlled Study Evaluating the Efficacy and Safety of etavopivat in children with Sickle Cell Disease.   
Principal Investigator(s)
1. Dr. Sharon Mokeira Ocharo
Site(s) in Kenya
1. Victoria Biomedical Research Institute (Kisumu county)
 
23-10-2026 View

3.

ECCT/26/05/01   C1091009 Study site 1193
    Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants   
Principal Investigator(s)
1. Janet Nyawira Oyieko
Site(s) in Kenya
1. KEMRI Butere Clinical Research Centre (Kakamega county)
2. Kenya Medical Research Institute Walter Reed Project (Kericho county)
3. Kenya Medical Research Institute (KEMRI) - Centre for Global Health Research (Kisumu county)
4. Victoria Biomedical Research Institute Kisumu County Referral Hospital (Kisumu county)
 
08-11-2026 View

4.

ECCT/26/04/01   ACRN-MNK02-301
    A Phase 3, randomized, double-blind, placebo-controlled trial to evaluate the effect of Bifidobacterium longum subsp. infantis DSM33361(Bifin02) administered together with Lacticaseibacillus rhamnosus GG DSM33156 (LGG ®) versus placebo on weight gain in underweight infants.       
Principal Investigator(s)
1. Prof. Videlis Nduba
Site(s) in Kenya
1. KEMRI-CRDR (Nairobi City county)
2. KEMRI-MTWAPA (Kilifi county)
3. Moi University Clinical Research Centre (Uasin Gishu county)
 
21-10-2026 View

5.

ECCT/26/03/03   LIBRA
    A 52-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group, group sequential, Phase 3 study to evaluate the efficacy and safety of rilzabrutinib in patients aged 10 to 65 years with sickle-cell disease (LIBRA)   
Principal Investigator(s)
1. Jessie Githanga
Site(s) in Kenya
Getrudes’s Children\'s Hospital
 
23-10-2026 View

6.

ECCT/26/03/01   C1091009 Study
    A Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants   
Principal Investigator(s)
1. Lucas Otieno Tina
Site(s) in Kenya
1. Victoria Biomedical Research Institute Kisumu County Referral Hospital (Kisumu county)
2. KEMRI Butere Clinical Research Centre (Kakamega county)
3. Kenya Medical Research Institute Walter Reed Project (Kericho county)
4. Kenya Medical Research Institute (KEMRI) - Centre for Global Health Research (Kisumu county)
 
26-08-2026 View

7.

ECCT/26/02/04   RSV IMPACT TRIAL
    A Phase-IIIb individually randomized, placebo-controlled trial on safety of RSVA/B-preF vaccine in pregnant women and efficacy against severe RSV-associated lower respiratory tract infection (LRTI) in infants.   
Principal Investigator(s)
1. Joyce Uchi Nyiro
2. Makobu Kimani
Site(s) in Kenya
1. Kilifi, KEMRI-Centre for Geographic Medicine Research Coast (CGMRC) (Kilifi county)
 
28-05-2026 View

8.

ECCT/26/02/03   REVIVE Study - KNH
    A randomised, double blinded, placebo-controlled, multicentre trial of azithromycin prophylaxis for advanced HIV disease   
Principal Investigator(s)
1. Loice Achieng Ombajo
Site(s) in Kenya
1. Kenyatta National Hospital (KNH) (Nairobi City county)
 
28-09-2026 View

9.

ECCT/26/02/02   REVIVE Study - JOOTRH
    A randomised, double blinded, placebo-controlled, multicentre trial of azithromycin prophylaxis for advanced HIV disease   
Principal Investigator(s)
1. Loice Achieng Ombajo
Site(s) in Kenya
1. Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH) (Kisumu county)
 
22-08-2026 View

10.

ECCT/25/12/05   Floral Study
    An open-label, multi-centre, rollover study to characterise long-term safety and efficacy of etavopivat in adults, adolescents and children who have sickle cell disease or thalassaemia and have completed a treatment period in an etavopivat study             
Principal Investigator(s)
1. Janet Oyieko
Site(s) in Kenya
1. Kombewa Clinical Research Center (Kisumu county)
2. Center for Research in Therapeutic Sciences (CREATES) (Kisumu county)
3. Gertrude\'s Children\'s Hospital (Nairobi City county)
4. KEMRI Siaya Clinical Research Annex (Siaya county)
5. KEMRI WALTER REED KERICHO (Kericho county)
6. KEMRI Kondele Children\'s Hospital (Kisumu county)
 
13-04-2026 View